We just received data on a new analyst forecast for $ARWR. Jason Gerberry from B of A Securities set a price target of 62.0 for ARWR.
To track analyst ratings and price targets for $ARWR, check out Quiver Quantitative's $ARWR forecast page.
Should you buy $ARWR?
Some analysts are better than others. To view the past performance of B of A Securities, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$ARWR Price Targets
Multiple analysts have issued price targets for $ARWR recently. We have seen 7 analysts offer price targets for $ARWR in the last 6 months, with a median target of $60.0.
Here are some recent targets:
- Keay Nakae from Chardan Capital set a target price of $60.0 on 12/01/2025
- Jason Gerberry from B of A Securities set a target price of $62.0 on 12/01/2025
- Michael Ulz from Morgan Stanley set a target price of $48.0 on 11/26/2025
- Andrea Tan from Goldman Sachs set a target price of $48.0 on 11/20/2025
- Luca Issi from RBC Capital set a target price of $52.0 on 11/19/2025
- Edward Tenthoff from Piper Sandler set a target price of $70.0 on 11/19/2025
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $80.0 on 10/08/2025
$ARWR Insider Trading Activity
$ARWR insiders have traded $ARWR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $ARWR stock by insiders over the last 6 months:
- JAMES C HAMILTON (Chief Medical Officer) has made 0 purchases and 5 sales selling 60,000 shares for an estimated $1,725,000.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ARWR Hedge Fund Activity
We have seen 171 institutional investors add shares of $ARWR stock to their portfolio, and 152 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DRIEHAUS CAPITAL MANAGEMENT LLC added 2,099,398 shares (+inf%) to their portfolio in Q3 2025, for an estimated $72,408,237
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 2,017,489 shares (+3142.5%) to their portfolio in Q3 2025, for an estimated $69,583,195
- DEERFIELD MANAGEMENT COMPANY, L.P. added 993,000 shares (+inf%) to their portfolio in Q3 2025, for an estimated $34,248,570
- JANUS HENDERSON GROUP PLC added 923,722 shares (+1853.2%) to their portfolio in Q3 2025, for an estimated $31,859,171
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 834,661 shares (+31.1%) to their portfolio in Q3 2025, for an estimated $28,787,457
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 822,343 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $28,362,610
- BLACKROCK, INC. added 799,938 shares (+4.1%) to their portfolio in Q3 2025, for an estimated $27,589,861
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
